close
Solutions
keyboard_arrow_downServices
keyboard_arrow_downSupport & Resources
keyboard_arrow_downCompany
keyboard_arrow_downContact
Randox Health search
The RIQAS Cardiac EQA programme is designed to monitor the performance of up to 7 clinically significant cardiac markers. Three flexible reporting options are available to suit the needs of all laboratory sizes.
Lyophilised material for enhanced stability
Submit results and view reports online via RIQAS.Net
Worlds largest EQA scheme ensuring peer groups are maximised
Flexible options available with bi-weekly or monthly reporting
Cycles Start: RQ9127 – March/September 2026
RQ9186 – March 2026
Accredited to ISO/IEC 17043:2023
Get in touch to discover more
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| Cardiac Bi-Weekly (2 Parameters) | Bi-Weekly | 12 x 1 ml | RQ9127/A | |
| Cardiac Bi-Weekly (7 Parameters) | Bi-Weekly | 12 x 1 ml | RQ9127/B | |
| Cardiac Monthly (7 parameters) | Monthly | 12 x 1 ml | RQ9186 |
Parameters
- CK, Total
- CK-MB (Activity)
- CK-MB (Mass)
- Homocysteine
- Myoglobin
- Troponin I
- Troponin T
Please note, product availability may vary country to country.
Related RIQAS EQA Programmes
Cardiac Plus
BNP
Lipid
